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Mitochondria and the culture of the
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Understanding the integration of mitochondrial function within the reticulum, the
cell, and the organism
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As endosymbionts, the mitochondria are unique among
organelles. This review provides insights into mitochon-
drial behavior and introduces the idea of a uniﬁed collec-
tive, an interconnected reticulum reminiscent of the
Borg, a ﬁctional humanoid species from the Star Trek
television series whereby decisions are made within their
network (or ‘‘hive’’), linked to signaling cascades that
coordinate the cross-talk between mitochondrial and
cellular processes (‘‘subspace domain’’). Similarly, mito-
chondrial dynamics are determined by two distinct proc-
esses, namely the local regulation of ﬁssion/fusion and
the global control of their behavior through cellular sig-
naling pathways. Indeed, decisions within the hive pro-
vide each mitochondrial unit with autonomous control of
their own degradation, whereby mitochondrial fusion is
inactivated and they become substrates for autophagy.
Decisions within the subspace domain couple signaling
pathways involved in the functional integration of mito-
chondria with complex cellular transitions, including
developmental cues, mitosis, and apoptosis.
Keywords: .fission; fusion; metabolism; mitochondrial dynamics;
signaling
The interconnected collective
Mitochondria evolved from a bacterial origin, as evidenced by
the mitochondrial genomic sequences that have been retained
throughout evolution [1]. Using genetic evidence and ultra-
structural resemblance as major arguments, Lynn Margulis
(Sagan) published a theoretical paper in 1967 postulating that
around 1–2 billion years ago, a proto-eukaryotic cell without
mitochondria (anaerobic archaebacteria) captured an a-proteo-
bacterium by endocytosis [2]. One of the consequences of the
endosymbiotic theory of mitochondria was the systemic concep-
tualization of these organelles as independent, rather incom-
municative structures that primarily function as the energy
powerhouse of the cell. Since most of the early metabolic
experiments were performed on isolated mitochondria
removed from their cellular milieu, scientists assumed that
the primary determinant of metabolic rates was based upon
the changes in the concentrations of metabolites. However,
just as bacteria continue to surprise us with their ability to
swarm and communicate within their colonies, the mitochon-
drial research community was equally surprised to learn that
the mitochondria are not individual structures; rather they
exist within an interconnected reticulum. Elegant studies in
Drosophila and yeast initially revealed that the mitochondria
are continually reshaped through ongoing fusion and ﬁssion
events. These experiments unleashed a new paradigm in
mitochondrial biology and have prompted a search for the
meaning of the dynamic behavior of these organelles. Later
work in both human and yeast systems led to the discovery of
other proteins involved in the core fusion and ﬁssion machin-
ery, thereby providing invaluable tools to manipulate the
shape of the reticulum. Using these tools has permitted a
greater understanding of the functional consequences of mito-
chondrial morphology.
However, the consequences of mitochondrial fusion and
ﬁssion processes during the normal functioning of cells
remain partly mysterious. Most certainly mitochondrial
plasticity facilitates the movement and careful placement of
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sthese organelles within the cell. This is well illustrated in
neurons,wheremitochondrialdeliverytothesynapserequires
the activation of signaling cascades to orchestrate the long
range motility along microtubules, followed by the arrest and
anchoring of mitochondria to the actin cytoskeleton [3, 4]. It
has also been shown that mitochondrial ﬁssion is a response
to hyperglycemia [5, 6], and represents an essential aspect of
mitochondrial quality control [7].
On the other hand, mitochondrial fusion is essential for
the maintenance of mitochondrial DNA [4, 8, 9], therefore
indirectly impacts on the rates of oxidative phosphorylation.
The signaling cascades that coordinate the cross-talk between
mitochondrial and cellular processes must now be identiﬁed,
which in Borg terms would be analogous to the ‘‘subspace
domain’’ that orchestrates their actions (Fig. 1). Indeed,
recent years have seen an explosion in this area, with
multiple signaling cascades emerging as key regulators of
the core ﬁssion GTPase, Drp1, which has been shown to be
SUMOylated [10], phosphorylated [11], ubiquitinated [12], and
perhaps even S-nitrosylated [13, 14].
Evidence has also emerged that mitochondria may signal
within their network (or ‘‘hive’’) in a manner similar to that
of a bacterial colony. This concept has not been widely con-
sidered within this context, but it is accepted that the coor-
dinated activity of the reticulum involves lateral signaling
cascades between the organelles. Functionally, this ensures
metabolic synchrony. The most direct example of this is illus-
trated by the apoptotic waves of cytochrome c release and
calcium ﬂux during a death trigger [15, 16]. Calcium waves
are propagated between organelles and represent a prime
example of lateral, inter-mitochondrial communication.
Moreover, retrograde signals are sent from the mitochondria
back to the nucleus, and have been the subject of a great deal
of research, primarily in yeast model organisms [17].
Retrograde signaling informs the nucleus of changing meta-
bolic demands initiated at the mitochondria, leading to an up
regulation of mitochondrial biogenesis [17–19].
Finally, it has been recently discovered by our laboratory
that the mitochondria also send ‘‘pods’’ or vesicles to another
intracellular organelle, the peroxisome [20, 21]. Our ongoing
research continues to reveal a much more communicative
system of membrane transport than previously envisioned.
As the ﬁeld of mitochondrial dynamics and signaling
evolves, our knowledge of mitochondria, from a passive fur-
nace that responds only to concentration gradients of metab-
olites into an organelle that functions as a signaling platform,
is greatly expanding.
Decisions within the hive
As recently proposed by Shirihai and coworkers [22], the
mitochondria respond to two distinct processes, namely
the local regulation of ﬁssion/fusion (within the hive) and
the global control of their behavior through cellular signaling
pathways (or within the subspace domain) (Fig. 1).
The local control of mitochondrial dynamics is not well
understood, although it is known to be functionally essential
[23–25]. In the mammalian system there are three large
GTPases that control mitochondrial fusion. The ﬁrst two
are outer membrane Mitofusins that have resulted from a
gene duplication event (compared to yeast and lower organ-
isms, which have only one Fzo1 GTPase to drive fusion). The
third GTPase is an intermembrane space oligomeric protein
called Opa1 that is required for both mitochondrial fusion
and in the regulated assembly of the inner membrane cristae
[26]. The essential nature of mitochondrial fusion for metab-
olism and mtDNA stability was initially demonstrated more
than 10 years ago in yeast model organisms [8], but has
recently gained attention with the development of animal
models lacking the fusion GTPases Mfn1 and/or Mfn2 [23, 27,
28]. Regardless of the tissue, the loss of Mfn2 leads to total
atrophy and cell death, stemming from a systemic loss of
mtDNA, accumulation of mtDNA mutations and metabolic
incompetence. These results pose the question of how
Figure 1. Controlling the mitochondrial collective. A single COS7 cell
is illustrated in the center with the mitochondria labeled using a yel-
low ﬂuorescent protein (shown in white). The steady state
morphology of the mitochondria is continually remodeled based on
local decisions within the ‘‘hive’’. The four images in the left panel
illustrate different dynamics, including branching, ﬁssion, clustering,
fusion, and swelling. Changes in the cellular state, including cell
cycle transitions, metabolic changes, stress, or cell death (right pan-
els) lead to the activation of signaling pathways within the ‘‘subspace
domain’’ that trigger global changes in the mitochondrial reticulum.
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smitochondrial fusion could affect mitochondrial DNA integ-
rity. Each cell can have hundreds of mitochondria, each
containing many copies of the 16 kB plasmid mitochondrial
DNA encoding tRNA, rRNA, and 13 proteins of the electron
transport chain. The theory resulting from this work is that
fusing the mitochondria will dilute any mutant mtDNA and
allow the wildtypegenomestocontributefunctionalelectron
transport chain components [27, 28]. Without fusion, these
mutant genomes would accumulate within individual organ-
elles, leading to their global dysfunction and presumably,
autophagic clearance. This model is not without its caveats.
The loss of Mitofusin2, for example, is believed primarily to
block mitochondrial fusion, which is certainly well estab-
lished. Moreover, Mfn2 is also a central component of the
mitochondrial contact sites with the endoplasmic reticulum
[29]. Loss of these contacts will also seriously compromise
calcium ﬂux, which in turn may contribute to the loss of
mitochondrial genomes. There is no certainty, however,
whether it is mitochondrial fusion, the ER contacts, or even
unknown functions of the mitofusins that are central to the
loss of metabolism and genome stability. This discussion
highlights the fact that much more work is required to under-
stand how fusion modulates mitochondrial function.
In contrast to the many unknowns in mitochondrial
fusion, examining the functional importance of mitochondrial
ﬁssion has led to an unexpected new paradigm in mitochon-
drial quality control. In 2008 it was ﬁrst shown that essentially
all mitochondrial ﬁssion events lead to the depolarization of
one of the ‘‘daughter’’ mitochondria and hyperpolarization
of the other [7]. This may be due to proton leakage during
membrane scission, or some other physical aspect of the
ﬁssion process. Importantly, the transient loss of potential
may provide an opportunity to survey the metabolic health
of the fragmented mitochondria. If they are actively respiring,
they will regain their potential within a short time, and
later fuse back into the reticulum. However, should they be
respiration deﬁcient, they would not regain potential.
Consequently, there would be two consequences of organelles
with low resting potential. Firstly, the protease Oma1 would
become activated within the mitochondrial inner membrane
and cleave the fusion GTPase Opa1, effectively exiling the
depolarized organelle from the collective [30, 31]. Secondly,
the loss of potential would lead to the stabilization of the
mitochondrial kinase PINK, and the recruitment of a ubiquitin
E3 ligase called Parkin [32–36]. Parkin recruitment leads to the
delivery of the depolarized organelle to the autophagosome
for degradation. Along the way, Parkin was also shown to
ubiquitinate Mfn1 [37, 38], providing a second hit in addition
to the inactivation of Opa1, that would block re-fusion of
this doomed organelle back into the reticulum. Together, this
series of observations has been a breakthrough in our under-
standing of the function of mitochondrial ﬁssion in steady
statequalitycontrol.Clinically,mutationsinPINK1andParkin
genesarecausalfor Parkinson’s disease, stronglysuggesting a
common defect in mitochondrial quality control as an under-
lying feature of neurodegenerative disease. However, it is still
unclear how the ﬁssion GTPase DRP1 (dynamin related
protein 1) is initially recruited to the mitochondria, or how
the ﬁssion site is chosen. Mathematical modeling of ﬁssion
andfusioninthecontextofqualitycontrolwouldindicatethat
the process is likely stochastic in nature [39], where there is no
theoretical need to actively identify dysfunctional regions of
the reticulum. The ongoing, dynamic process of mixing and
separating would eventually cull the damaged regions within
the reticulum.
The subspace domain
Ithas becomemost apparent that the levelof interconnectivity
within the mitochondrial reticulum changes between cell
types and also during most cellular transition states. This
makes it clear that the reticulum is highly responsive to the
‘‘subspace domain’’, or the communication networks inherent
in cell signaling paradigms. In fact, it has been the investi-
gation of cell cycle, apoptosis, differentiation, and the stress
responses that provided most information about the intersec-
tion between signaling cascades and changes in mitochon-
drial morphology and function. Most notable is the
modulation of mitochondrial shape through the use of sig-
nal-driven posttranslational modiﬁcations by kinases, phos-
phatases, and ligases (Fig. 2).
Ensuring transmission through the generations:
Dynamics and the cell cycle
Global mitochondrial fragmentation is observed during mito-
sis, where it is thought to facilitate the segregation of the
reticulum into daughter cells [40, 41], and during apoptosis,
where the smaller fragments seem to accelerate the release of
cytochrome c [42, 43]. In contrast, the mitochondria become
highly fused during the growth phase of G1 [44], and in
response to multiple forms of stress [45]. The latter was shown
in work by the Martinou group who observed hyperfused
mitochondria as an early response to cellular stresses includ-
ing UV irradiation (UV-C), actinomycin D, and cycloheximide.
Mechanistically they revealed a critical role for a prohibitin-
like protein Slp-2 to maintain Opa1 in a fusogenic form within
the intermembrane space [45]. It was speculated that fusion
during stress would unify the reticulum to buffer them against
damage and increase ATP production during this period,
although the underlying mechanism has not been elucidated
yet. It has been established that the mitochondria fuse into a
highly interconnected network in G1/S [40, 41, 44, 46]. More
recently it was concluded that the hyperfusion of mitochon-
dria was required for the buildup of cyclin E and entry into
S phase [44]. Consistent with this, the induction of fusion
upon inhibition of Drp1 by the drug mDivi triggered entry into
S phase, bypassing the requirement for growth factors [44]. It
is unclear whether the increased oxidative phosphorylation
resultingfromthefusednetworkissufﬁcient totriggerSphase
entry.
Alternatively, the fused reticulum could trigger down-
stream signaling events leading to S phase entry. If changes
in mitochondrial dynamics are important for the regulation of
the G1/S transition, this raises the possibility that cell-cycle
regulators, in addition to controlling mitochondrial bio-
genesis, will also regulate the fusion or ﬁssion machineries.
Possible candidates may be from the mTOR pathways that
signal cell growth and proliferation. Indeed a number of
E. Braschi and H. M. McBride Prospects & Overviews....
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dria [47–49] and future work may uncover evidence of signiﬁ-
cant cross-talk between the transitions in mitochondrial
dynamics, cell growth, and division.
There is also emerging evidence that the mitochondrial
collective shifts into a fragmented state under diabetic con-
ditions of high glucose levels [5, 50, 51]. The molecular bases
for this increased DRP1 activity, or the extent of inhibition of
fusion are still unclear. Fragmentation also occurs during
ischemia-reperfusion injury [52] and during cell death [53],
where DRP1 recruitment is stabilized [54]. Again, the molecu-
lar bases for this are not yet clear, although the dephosphor-
ylation of DRP1 by calcineurin plays a role in at least some of
these circumstances [55, 56]. Importantly, the inhibition of
DRP1-induced fragmentation has been shown to be protective
in physiological models of disease, including Parkinson’s
disease [57, 58] and ischemia-reperfusion injury models [52],
providing hope for future therapeutic development.
Preparing to abandon ship: The collective kills the host
Oneoftheearliesttransitionsinthesubspacedomaintosignal
the collective fragmentation of the mitochondria is the
initiation of programmed cell death [42]. Mitochondrial frag-
mentation clearly accompanies cell death, and inhibiting
apoptotic ﬁssion delays the death program. However it is still
unclear what the molecular purpose of the ﬁssion process
really is. How do smaller mitochondria promote the formation
of apoptotic pores that release the factors essential for cell
death? Perhaps the fragmentation process is a side-reaction
where the ﬁssion promoting machinery may have a secondary
role in lipid organization, cristae remodeling and/or pore
assembly [59–61]. A great deal of interest continues to focus
on obtaining answers to these questions.
Finally, there is a much broader question to consider when
thinking about apoptosis. From the perspective of the uniﬁed
collective, how did the mitochondria get involved in the
apoptotic program in the ﬁrst place? Considering the unique
evolutionary history of the mitochondria, one wonders
whether the control of apoptosis could have developed from
their bacterial origin. Although the considerable phylogenetic
distance makes it difﬁcult to draw functional inferences from
limited sequence similarities, the Bcl-2 family of proteins
appears to be structurally related to bacterial pore-forming
toxins, for example, colicins, and diphtheria toxin [62]. In
addition, components of the apoptotic machinery including
VDAC, cyclophilin, cytochrome c, and the adenosine nucleo-
tide carrier appear to be conserved in bacteria [63]. It has been
suggested that the replication advantage given to the pre-
mitochondria may be related to the production of a long-lived
toxin from which the bacteria-produced Bcl-2 ‘‘antidote’’
could rescue the host. Should the pre-mitochondria have been
lost, then the longer-lived toxin would kill the host. This type
of selection may have stabilized the host/parasite relationship
and may represent the precursor stage to the mitochondria-
dependent apoptotic machinery [64]. Important to this model
is the idea that one ‘‘rogue’’ mitochondrion must not attempt
to kill the cell on its own, which may also explain the need for
the reticulum to function in synchrony.
Figure 2. Signaling modules and switches that orchestrate mito-
chondrial behavior. This ﬁgure illustrates some of the complex post-
translational modiﬁcations discussed within the text. Mitochondrial
ﬁssion is achieved through the recruitment and oligomerization of the
Dynamin Related Protein DRP1. There is evidence that this protein is
SUMOylated, phosphorylated, and ubiquitinated, all of which will
impact the activity of DRP1 in unique and overlapping ways.
Modifying enzymes include MAPL, a SUMO E3 ligase, Protein kinase
A, and cyclin B (kinases), and MarchV/Mitol (a ubiquitin E3 ligase).
Deconjugating enzymes include SenP5 (a SUMO protease), calci-
neurin (a phosphatase), and potential deubiquitinating enzymes
(DUBs) that have yet to be identiﬁed. Phosphorylation by PKA inhibits
the recruitment of DRP1, while phosphorylation at a different site by
Cyclin B promotes mitochondrial ﬁssion during mitosis. Mitochondrial
fusion is regulated primarily through the proteolytic cleavage of the
intermembrane space GTPase Opa1, and through the regulation of
mitofusin (more clearly shown for yeast Fzo1) protein levels by ubiq-
uitination. Mitochondrial fusion is inhibited during cell death and upon
loss of electrochemical potential, and is stimulated in mild stress
conditions and during G1/S. The combinatorial use of these modiﬁ-
cations has not yet been tested directly in experimental models and
there is much more to be discovered.
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The role of SUMOylation in mitochondrial fission
This section will focus on our working hypothesis for some of
the mechanisms that directly couple the subspace domain to
changes within the mitochondrial hive. The most progress has
been made in the identiﬁcation of post-translational modiﬁ-
cations of the ﬁssion GTPase DRP1. The ﬁrst of these was the
observation that DRP1 may be covalently conjugated to
SUMO1, a process that was shown to stimulate mitochondrial
fragmentation[10].Thesmallubiquitin-likemodiﬁerproteinis
similar to ubiquitin in the enzymology of conjugation, requir-
ing an E1, E2, and E3 ligase to conjugate the  100 amino acid
protein to a conserved lysine residue in the target [65]. In 2004
SUMOylation was primarily thought to function within the
nucleus, so the identiﬁcation of a number of SUMO-immuno-
reactive proteins on the mitochondria was unexpected. The
cycle of SUMO- and deSUMOylation is often used as a switch
mechanism to initiate large protein complex assembly, or to
disassemble them, as in the case of the septin GTPases [66–
68]. It is also used to reveal nuclear targeting signals and
facilitate transport across the nuclear envelope. So what was
the function of DRP1 SUMO conjugates? The collective evi-
dence indicates that SUMOylation is not essential for mito-
chondrial ﬁssion, rather the cycle of SUMOylation and de-
SUMOylation can promote mitochondrial ﬁssion, both in cell
death [54] and at the G2/M transition [41]. In this way,
SUMOylation is a regulator of mitochondrial ﬁssion that acti-
vates the process during speciﬁc cellular transitions. This has
been shown through the identiﬁcation of the functional SUMO
protease SenP5 [69], and the characterization of the mitochon-
drial outer membrane SUMO E3 ligase, MAPL (Mitochondrial
anchored protein ligase) [70], which has also been called
MULAN[71] orGIDE[72]. Experiments to reducemitochondrial
SUMOylation, either by overexpressing SenP5 or silencing
MAPL, lead to a reduction in DRP1 SUMOylation, and in the
case of SenP5 expression, increased mitochondrial connec-
tivity. In contrast, experiments that increased mitochondrial
SUMOylation, either by overexpressing MAPL, silencing
SenP5, or overexpressing SUMO, lead to elevated mitochon-
drial fragmentation and higher levels of DRP1:SUMO1 conju-
gates [10, 69, 70].
Furthermore, these studies have shown that conditions of
increased DRP1 SUMOylation stabilize the protein against
degradation within solubilized cellular extracts, which may
be indicative of a conformational shift. Together, these exper-
iments have consistently shown that SUMOylation is a pro-
ﬁssion process.
Mechanistically it has been more difﬁcult to determine
what exact step the DRP1 SUMOylation cycle may promote.
DRP1 is a complex protein that undergoes a number of mol-
ecular transformations that are required to constrict and sep-
arate the mitochondrial tubule. These include its initial
recruitment, the initiation of oligomer assembly, GTP hydroly-
sis, and membrane constriction, scission, and ﬁnally,
oligomer disassembly [73]. In the absence of the staged cell-
free reconstitution of these steps in mammalian systems, one
can only extrapolate on the existing biochemical and dynamic
analysis of DRP1 function. Site directed mutagenesis studies
done by the Feldman group have identiﬁed a number of
potential sites within the middle ‘‘B domain’’ that were con-
jugated to SUMO1, SUMO2, and SUMO3 [74]. This domain is
analogous to the PH domain of Dynamin 1 [74]. While
mutations of all three sites rendered the protein SUMO-con-
jugation deﬁcient, initial mitochondrial recruitment was still
observed. This is consistent with our evidence that the loss of
the mitochondrial SUMO E3 ligase MAPL did not signiﬁcantly
affect the overall morphology of the mitochondria in steady
state [20]. Our more recent work with the SUMO protease
SenP5 has shown that just prior to the breakdown of the
nuclear envelope during the G2/M transition, SenP5 trans-
locates to the mitochondrial surface, where it accelerates
the SUMO- and deSUMOylation cycle, promoting mitochon-
drial fragmentation [41]. This was shown using photobleach-
ing studies that revealed an increase in the rates of DRP1-YFP
recycling on and off the mitochondrial membrane in mitosis
compared to cells in interphase. A signiﬁcant increase in the
oligomeric forms of DRP1 in mitotic cells, consistent with a
higher fraction of functional ﬁssion sites during this time, was
also observed.
Concomitantly,therewasadecreaseintotalmitochondrial
(and DRP1) SUMOylation when SenP5 was delivered to the
membrane during mitosis. Functionally, the silencing of
SenP5 led to a cell cycle arrest at G2/M, suggesting that its
delivery to the mitochondria may be an important cell cycle
checkpoint, although the loss of deSUMOylation activity
within the nucleus could also have been responsible for this
arrest [41].
In contrast to the acceleration of DRP1 recycling during
mitosis, apoptotic fragmentation, which is considered irre-
versible, led to the Bax/Bak-dependent stable SUMOylation
of DRP1 on the mitochondrial membranes, which coincided
with a complete loss in recycling off the mitochondrial mem-
brane [54]. The block in DRP1 recycling and stable
SUMOylation occurred after mitochondrial fragmentation
was completed, suggesting a potential role for
deSUMOylation in the disassembly of DRP1 oligomers. Our
combined studies in cell cycle and cell death have led to the
development of a working model, proposing that the initial
recruitment of DRP1 may be primarily based on lipid binding
afﬁnities, akin to the PH domain of Dynamin 1. DRP1
SUMOylation may alter its conformation in order to enhance
the retention of DRP1 on the membrane and association with
the downstream partners like Fis1 and Mff. As an outer mem-
brane protein, the SUMO E3 ligase MAPL could SUMOylate
DRP1 following recruitment.
Given the precedents already set for other SUMO sub-
strates, it is likely that the SUMOylated form of DRP1 is very
transient, withdeSUMOylation following quicklyas partof the
process of conformational change. During mitosis, this entire
cycle would be enhanced by the delivery of the SUMO pro-
tease. In contrast, during cell death, SUMOylation leads to a
post-ﬁssion form of DRP1 that is trapped on the mitochondrial
membrane. This may be consistent with the increase in
SUMOylation observed in the GTP binding mutant DRP1/
K38A [74], where following GTP hydrolysis, SUMOylation
may occur as a mechanism to disassemble the oligomers
following constriction. The increased SUMOylation of this
mutant would also suggest that MAPL preferentially
E. Braschi and H. M. McBride Prospects & Overviews....
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would be consistent with the SUMOylation of the initially
recruited protein, as well as a role for the SUMOylation cycle
to diassemble the DRP1 oligomer post-ﬁssion. In this way
SUMOylation is envisioned as playing a ‘‘chaperone-like’’
function in the transitioning of DRP1 into and out of the
oligomers.
Additional DRP1 modifications couple fission to the
cellular state
Subsequent to the identiﬁcation of DRP1 SUMOylation, it has
been shown that DRP1 also undergoes a number of regulated
phosphorylation events (Fig. 2). It was ﬁrst demonstrated that
DRP1 Ser585 is phosphorylated by Cdk1/CyclinB upon the
onset of mitosis, a modiﬁcation that was shown to increase
its recruitment and drive mitochondrial ﬁssion for efﬁcient
segregation into the two daughter cells [40]. Since then, DRP1
was also shown to be phosphorylated by protein kinase A
(PKA) at Ser637, which inactivates the GTPase, leading to an
inhibition of mitochondrial ﬁssion and protection against cell
death [11, 75]. On the other hand, increased Ca
2þ concen-
trations activate the phosphatase calcineurin which dephos-
phorylates DRP1/Ser637 thereby restoring DRP1 recruitment to
the mitochondria, leading to increased fragmentation [11, 56].
The recent use of a peptide inhibitor of calcineurin has
extended these studies, showing how the retention of DRP1
in the phosphorylated state during cell death was highly
protective [55]. Importantly, it is possible that, in vivo, phos-
phorylation events would be coupled to a second post-trans-
lational modiﬁcation, which could inﬂuence GTPase or
oligomer assembly. For example, the phosphorylation of
Ser637of Drp1byPKAwasﬁrstshowntoinhibitDRP1 function
[11, 75]. However, phosphorylation of this same serine residue
by the Ca
2þ/Calmodulin-dependent protein Kinase I a
(CaMKIa) was shown to increase the translocation of Drp1
to the mitochondria, and to trigger mitochondrial fragmenta-
tioninneurons[76].Interestingly,thislaststudyexaminedthe
neuron speciﬁc Drp1, which lacks a region of the Variable
Domain. This domain is alternatively spliced in different Drp1
isoforms.
Interestingly, the spliced domain contains SUMOylation
sites [74].Hence,depending on theSUMOylationstate ofDrp1,
the phosphorylation of DRP1 on Ser637 would either increase
or decrease ﬁssion rates. These examples highlight the com-
plexity of understanding the regulation of Drp1 since the
consequences of a speciﬁc post-translational modiﬁcation
may vary depending on the cellular context and on the
presence of multiple post-translational modiﬁcations.
Ubiquitination may also play a role in the regulation of
DRP1 activity [12, 77–79]. The downregulation of a mitochon-
drial-anchored ubiquitin E3 ligase Membrane Associated Ring
Finger 5 (MARCHV) promotes the recruitment of Drp1 to the
mitochondria [12, 79]. However, FRAP studies have demon-
strated that the enrichments formed by DRP1 are not as
dynamic, which leads to a decrease in mitochondrial ﬁssion
and to a reticular phenotype. It is therefore possible that the
ubiquitination of DRP1 is also a requisite for the formation of
active oligomers post-recruitment [12]. This would indicate a
requirement for a speciﬁc mitochondrial deubiquitination
enzyme (DUB) for DRP1, which has not yet been identiﬁed.
More recent work with MARCHV has also shown that Mfn1 is a
likely substrate, since Mfn1 protein levels are increased upon
silencing of MARCHV, which contributes to the fused pheno-
type [79]. This is reminiscent of the function of the yeast Skp-
Cullin ubiquitin E3 ligase Mdm30, which regulates the turn-
over of the yeast orthologue of the human mitofusins, Fzo1
[80–82]. Therefore ubiquitin E3 ligases are also acting on the
ﬁssion/fusion machinery in order to regulate their activity, by
promoting degradation and also through non-proteasomal
pathways.
Glitches in the collective: The path to
disease
The smooth functioning of the mitochondrial reticulum
appears to depend entirely upon an ability to respond to
global and local cues in order to shift morphology and pos-
ition. It has become increasingly evident that a number of
human diseases may be directly caused by the disruption of
the mitochondrial reticulum [83]. The most obvious links to
disease are neurodegenerative conditions where proteins
of the morphology machinery are mutated, most notably
Charcot-Marie Tooth Type 2A and Dominant Optical
Atrophy [83]. However more common neurodegenerative dis-
eases including Alzheimer’s [13, 84], Huntington’s [85, 86],
and Parkinson’s disease [87] are also directly linked to mito-
chondrial dysfunction. These diseases, as with the ischemic
conditions associated with heart disease and stroke [52], may
stem from a reduction in mitochondrial quality control path-
ways, which, as discussed above, are acutely dependent upon
ongoing plasticity within the network. Mitochondria have also
made recent, unexpected appearances in many laboratories
interested in immunology and septic shock. The ﬁrst example
was the identiﬁcation of a core component required to signal
viral infection and activate the immune response. An outer
mitochondrial membrane protein called MAVS functions as
the ‘‘launchpad’’ for the Nf-kB and type I IFN antiviral tran-
scriptional response [88–91]. Why this immune complex must
be localized to the mitochondria is not yet clear, although the
proximity to the apoptotic machinery is unlikely to be a
coincidence. The goal of the infected cell is to stave off death
until it is able to alert the neighboring cells of the viral
invasion, so placing the signaling pathway that releases inter-
feronswithintheapoptotic organelle mayallow thetemporary
inhibition of cell death [92]. Consistent with this, a number of
recent publications have also linked MAVS activity to the
activation of mitochondrial fusion [93, 94], which is known
to be protective against cell death [43].
Finally, the evolutionary origins of the mitochondrion as a
potential pathogen have emerged once again in a recent study
with a great deal of relevance to emergency room physicians
[95]. It has been long known that various bone fractures or
trauma injuries lead to a toxic shock response that utilizes the
same molecularpathways as those engaged insevere bacterial
infections, although the reason for this was unknown. It
has now become clear that mitochondria released from
the ruptured cells are the culprit [96]. It appears that their
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tides translated by their own mitochondrial ribosomes are
recognizedasthebacteriathattheyoncewere.Theseelements
of the released mitochondria were shown to directly activate
the Toll-like receptors on immune cells within the circulation,
prompting the critically dangerous shock response. In this
case, those mitochondria liberated from the ‘‘collective’’ bind
to the receptors of potential host cells, which in an odd turn of
events, takes them back to earlier times, even if it was about a
billion years ago.
Conclusions
Much has been written on the importance of mitochondrial
dynamics in cellular function.
This essay has focused on the concepts that have emerged
to explain the responsiveness of the mitochondria to both
global and local cues. There are many holes that remain in
our understanding of the signaling pathways that activate
mitochondrial fusion or ﬁssion, meaning that we do not yet
comprehend the ‘‘subspace domain’’ to which the mitochon-
dria are intimately coupled. What is known is that, much to
our initial surprise, the mitochondria function as a highly
orchestrated reticulum within cells. This, combined with
the fact that the mitochondria have acquired most of their
proteins from the host to become a truly hybrid organism,
have led to a responsive and effective organelle. The Borg of
Star Trek are an interconnected collective focused on the
assimilation of other life forms in order to achieve perfection.
In the case of the mitochondria, it must be concluded that the
culture of the Borg will ultimately beneﬁt us all.
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